Thrombolysis utilisation in acute myocardial infarction in Bahrain

Indian Heart Journal

Volumn 48, Issue 2, 1996, Pages 155-158

  Chawla, A K ^a   Nambiar, C A ^a   Murad, A A ^a  

^a SALMANIYA MEDICAL COMPLEX   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BAHRAIN; BLOOD CLOT LYSIS; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; BAHRAIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; RETROSPECTIVE STUDIES; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0029906338     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gruppo Italiano per lo Studio della Streptochinasinell' Infarto Micardico (GISSI). Effectiveness of thrombolytic treatment in acute myocardial infarction. Lancet 1986; i: 397-402
2. ISIS-2 (Second International Study of Infarct Survival) collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; ii: 349-360
3. Yusuf S, Sleight P, Held P, McMahon S. Routine management of acute myocardial infarction: lessons from overviews of recent randomized controlled trials. Circulation 1990; 82 (Suppl 11): 117-134
4. Grines CL, DeMaria AN Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol 1990; 16: 223-231
5. Muller DW, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med 1990; 113: 949-960
6. Cragg DR, Friedman HZ, Bonema JD, et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991; 115: 173-177
7. Solomon B, Edward E, Avi C, et al. Frequency of use of thrombolytic therapy in AMI in Israel. Am J Cardiol 1991; 68(13): 1291-1294
8. Althouse R, Maynard C, Cerqueira MD, Olsufka M, Ritchie JL, Kennedy JW. The Western Washington myocardial infarction registry and emergency department tissue plasminogen activator treatment trial. Am J Cardiol 1990, 66: 1298-1303
9. Karlson BW, Herlitz J, Edvardson N, Emanuelson H, Syolin M. Eligibility for intravenous thrombolysis in suspected acute myocardial infarction. Circulation 1990; 82: 1140-1146
10. Shah PK. The role of thrombolytic therapy in patients with acute myocardial infarction presenting later than six hours after the onset of symptoms. Am J Cardiol 1991; 68: 72C-77C
11. Becker RC. Late thrombolytic therapy: mechanism of benefit and potential risk among patients treated beyond 6 hours. Coronary Artery Dis. 1993; 4: 293-304
12. Hendra TJ, Marschall AJ. Increased prescription of thrombolytic treatment to elderly patients with suspected acute myocardial infarction associated with audit. Br Med J 1992; 304: 423-425
13. Anderson HC, Willerson JT. Thrombolysis in acute myocardial infarction. Review article. N Eng J Med 1993; 329(10): 703-709
14. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682
15. Fuster V. Coronary Thrombolysis - A perspective for the practicing physician. Editorial. N Eng J Med 1993; 329(10): 723-724